More than 100 million people in the United States suffer from metabolic dysfunction-associated steatotic liver disease (MASLD ...

Leveraging human organoid-based mechanistic investigation, researchers reveal how an immunosuppressive drug, antithymocyte ...

In a human organoid-based mechanistic investigation, researchers revealed how an immunosuppressive drug, antithymocyte ...

More than 100 million people in the United States suffer from metabolic dysfunction-associated steatotic liver disease (MASLD ...

Federal prosecutors say a Houston doctor has been indicted on charges of falsifying medical records for five patients, making ...

This webinar explores how liver microphysiological systems support toxicology from early screening to species-specific risk assessment study design and mechanistic insight into drug-induced liver ...

The CMU spinout already trained on records from millions of Taiwanese patients, with early testing showing a 50% to 70% ...

More than 100 million people in the United States suffer from metabolic dysfunction-associated steatotic liver disease (MASLD), characterized by a ...

Colorectal cancer has long baffled scientists because, unlike most tumors, patients often do better when their cancers are ...